Friday 26th August, 2016   |   Welcome, guest. Please, login or register  
Friday October  9, 08:06

Statins, the new panacea?

Statins could reduce the risk of various malignancies, including those of prostate and breast
Statins could reduce the risk of various malignancies, including those of prostate and breast
 

Statins are lipid-lowering drugs, they reduce the rate of blood fats and are prescribed as prevention and treatment of cardiovascular diseases (i.e. venous thrombosis).

But not only cardiovascular disease is the reason to take statins. Patients with ischemic stroke (as opposed to hemorrhagic stroke) who were taking statins before this health problem or received them within three days of stroke, have a better prognosis than others.

Probably because of vasodilatory and anti-inflammatory functions of medication. More recently, researchers have shown the benefits of this product in chronic obstructive pulmonary disease, a debilitating respiratory illness.

Recent good news concerning cancer treatment also suggest statin as a helpful drug. The epidemiological and biochemical data have recently suggested that statins could reduce the risk of various malignancies, including those of prostate and breast. A retrospective study just presented at Breast Cancer Symposium, now in San Francisco, shows that taking statins is associated with a decreased risk of recurrence after breast cancer.

Dr. Chae and colleagues at the Albert Einstein Medical Center in Philadelphia reviewed between 1999 and 2005 the records of 707 women diagnosed with breast cancer stage II/III .

The monitoring of these patients ranged between 4.4 and 9.8 years and 20% of them had taken statins for at least six months. The recurrence rate was 9.4% among users against 24% among nonusers of statins.

Result: The risk of recurrence was reduced by 67% when taking statins. But the researchers say, that the use of statins is not associated with a reduction in overall mortality among women treated for breast cancer.

 
 
Rate:
 
 

Recommended articles:

 

A drug against stroke may influence breast cancer

A drug to fight against stroke may influence breast cancer by destroying malignant cells without affecting healthy cells
A drug against stroke may influence breast cancer by destroying malignant cells without affecting healthy cells, said Thursday the Israeli researchers.
 

Should we all take cholesterol-lowering drugs?

Statins may be prescribed to individuals without cardiovascular disease or apparent high LDL cholesterol, but considered at risk for cardiovascular disease
In the U.S., these cholesterol drugs are now allowed for a growing number of people without high cholesterol. To a significant cost.
 

More than 5 gramms of salt per day: Why is it really bad?

More than five grams of salt per day leads to stroke and cardiovascular disease
Eating too much salt increases the risk of stroke and cardiovascular disease, according to a study released November 25 on the website Bmj.com.
 

Most recent in the category Cancer:

 
 
 

Last comments

 

No comments. Be the first to comment the article!

 
Please, login or post your comment anonymously.

Your comment:

 
 
 
 
 

Home | Social Health | AIDS | Cancer | Diseases | Diet | Human body | Most read | Top rated

RSS | Feedback | Headlines for your website | Terms of Service/Privacy policy

Copyright © 2016 Heal-all.org. All rights reserved.